Effects of a dietary intervention with conjugated linoleic acid on immunological and metabolic parameters in children and adolescents with allergic asthma – a placebo-controlled pilot trial

Table 3 Routine haematological parameters

Parameter	Placebo		CLA		P value
	Start	End	Start	End	gr^a	gr × ti^b
Cholesterol (mmol/L)	4.48 ± 0.66	4.39 ± 0.78	4.32 ± 0.76	4.29 ± 0.77	0.641	0.779
TAG (mmol/L)	1.28 ± 0.69	1.29 ± 0.96	0.90 ± 0.60	0.92 ± 0.55	0.043	0.494
Creatinine (mmol/L)	66.3 ± 11.6	64.4 ± 9.3	62.3 ± 5.5	63.9 ± 7.9	0.484	0.103
ASAT (μmol/L × s)	0.49 ± 0.11	0.44 ± 0.09	0.49 ± 0.07	0.48 ± 0.08	0.562	0.186
ALAT (μmol/L × s)	0.56 ± 0.13	0.55 ± 0.22	0.53 ± 0.10	0.49 ± 0.09	0.885	0.291

Data are expressed as means ± SD; ^astudy group (placebo/CLA), ^bstudy group (placebo/CLA) × study time point (start/end); ALAT – alanine aminotransferase, ASAT – aspartate aminotransferase, TAG – triacylglycerol

ISSN: 1476-511X